Careventures

Centogene is a prominent genetic biotech company specializing in the diagnosis and analysis of rare inherited diseases. Headquartered in Rostock, Germany, with additional operations in Berlin and Cambridge, Massachusetts, Centogene focuses on transforming clinical, genetic, and biochemical data into actionable medical solutions. The company serves a diverse global patient population and aims to enhance awareness and understanding of rare diseases across various ethnicities. Centogene operates in two main segments: diagnostics, which offers targeted genetic sequencing and diagnostic services, and pharmaceuticals, which collaborates with partners to provide services such as patient recruitment, biomarker discovery, and epidemiological insights. Through its comprehensive approach, Centogene is dedicated to advancing the field of human genetics and improving the lives of patients and their families affected by rare diseases.

Corus Dental is a supplier of dental solutions and a manufacturer of dental medical devices, focusing on the technological transformation of dental prosthetics. The company provides a range of services that enhance the daily treatment process, ensuring alignment between clinician expectations and patient needs. Their offerings include digital workflow solutions, technical support, logistics, health product management, and high-fidelity management information. Additionally, Corus Dental specializes in orthodontic equipment, utilizing advanced technology to improve patient care and outcomes.

Qovetia is a business that connects canine, equine, and rural veterinarians with the aim of fostering collaborative clinic development based on shared values. It provides recruitment and training services tailored to veterinarians, offering educational resources for learning professionals and supporting them until they secure employment, thereby enhancing their skills and facilitating career progression.

Centogene is a prominent genetic biotech company specializing in the diagnosis and analysis of rare inherited diseases. Headquartered in Rostock, Germany, with additional operations in Berlin and Cambridge, Massachusetts, Centogene focuses on transforming clinical, genetic, and biochemical data into actionable medical solutions. The company serves a diverse global patient population and aims to enhance awareness and understanding of rare diseases across various ethnicities. Centogene operates in two main segments: diagnostics, which offers targeted genetic sequencing and diagnostic services, and pharmaceuticals, which collaborates with partners to provide services such as patient recruitment, biomarker discovery, and epidemiological insights. Through its comprehensive approach, Centogene is dedicated to advancing the field of human genetics and improving the lives of patients and their families affected by rare diseases.